Lack of evidence raises questions on long-term PPI use
There is rising concern over the side effects of long-term proton pump inhibitor (PPI) use but limited evidence to warrant discontinuation, a literature review...
New Parliamentary Friendship Group champions safer medicines use
The PSA has supported the launch of the inaugural Parliamentary Friends of Safe and Quality Use of Medicines event, using the opportunity to call...
Are your CPD activities up to date?
With the fast-approaching 30 September marking the end of the current CPD year, pharmacists should take stock of the progress of their CPD plans....
Case study: Uncovering Josef’s asthma flare-ups
If your patient is experiencing an increase in the frequency or severity of asthma symptoms or an increased reliance on their asthma inhaler, allergies could be the hidden cause.
NSW pharmacists given special authority to supply essential medicines
NSW has granted pharmacists a landmark special authority to supply most S4 medicines without a prescription to those affected by bushfires.
The NSW Chief Health...
Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
